Rmb Capital Management, LLC Biomarin Pharmaceutical Inc Transaction History

Rmb Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $11,330 - $15,208	140 Added 4.12%	3,540 $366,000
Q1 2022 May 06, 2022	SELL	$74.28 - $92.69 $252,552 - $315,146	-3,400 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$74.73 - $90.69 $254,082 - $308,346	3,400 New	3,400 $257,000
Q4 2020 Feb 11, 2021	SELL	$72.61 - $90.2 $246,874 - $306,680	-3,400 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$71.87 - $131.03 $53,040 - $96,700	-738 Reduced 17.83%	3,400 $259,000
Q2 2020 Aug 05, 2020	BUY	$79.55 - $124.22 $329,177 - $514,022	4,138 New	4,138 $510,000
Q1 2020 May 11, 2020	SELL	$71.37 - $96.85 $243,657 - $330,645	-3,414 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $19,074 - $24,086	-283 Reduced 7.65%	3,414 $230,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $12,461 - $14,595	148 Added 4.17%	3,697 $328,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $16,028 - $21,214	-200 Reduced 5.33%	3,549 $302,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $352,106 - $396,344	3,749 New	3,749 $364,000
Q2 2018 Aug 13, 2018	BUY	$76.01 - $99.03 $15,354 - $20,004	202 Added 5.69%	3,751 $0
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $270,990 - $323,186	-3,489 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $281,771 - $331,908	3,489	3,489 $311,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.